Stocks of the Hour: Immutep, Lepidico, Mithril Silver and Gold
Stocks of the Hour: Immutep, Lepidico, Mithril Silver and Gold
Immutep (ASX:IMM) has reported that eftilagimod alpha (efti) combined with MSD's KEYTRUDA shows high efficacy and a favourable safety profile for treating head and neck cancer. The TACTI-003 trial revealed a 31.0% overall response rate in patients with high PD-L1 expression, highlighting efti's potential to improve treatment outcomes without added toxicity. Shares are trading 12.5 per cent lower at 35 cents.
Immutep (ASX:IMM)報告稱，eftilagimod alpha（efti）與默沙東的KEYTRUDA聯合治療頭頸癌表現出高效性和良好的安全性。TACTI-003試驗顯示，高PD-L1表達患者的總體有效率爲31.0%，突顯了efti在不增加毒副作用的情況下改善治療效果的潛力。股價下跌12.5%，爲每股35美分。
Lepidico's (ASX:LPD) Trelavour Hard Rock Project has been named a Nationally Significant Infrastructure Project by the UK Government, endorsing its lithium processing technologies. The £9 million demonstration plant, using Lepidico's L-Max and LOH-Max technologies, is nearing completion and will produce battery-grade lithium hydroxide. Shares are trading 50 per cent higher at 0.3 cents.
Lepidico（ASX:LPD）的Trelavour硬巖項目被英國政府評爲具有國家重要性的基礎設施項目，爲其鋰處理技術背書。價值900萬英鎊的示範工廠採用Lepidico的L-Max和LOH-Max技術，即將竣工，將生產電池級別的羥化鋰。股價上漲50%，爲每股0.3美分。
Mithril Silver and Gold (ASX:MTH) LiDAR survey of the Copalquin District in Mexico uncovered over 100 historic mining sites, revealing extensive geology and structural details. This discovery highlights the district's potential as a major gold-silver system. The company is advancing its drilling and TSXV listing efforts. Shares are trading 40 per cent higher at 17.5 cents.
Mithril Silver and Gold（ASX:MTH）對墨西哥Copalquin地區進行的激光雷達調查發現了100多個歷史礦山遺址，展現出廣泛的地質和構造細節。這一發現突顯了該地區作爲一個重要的金銀系統的潛力。該公司正在推進鑽探和在tsxv上市的努力。股價上漲40%，爲每股17.5美分。
